ALLENA PHARMACEUTICALS, INC.
Biotechnology, 1 Newton Executive Park, Newton Lower Falls, Massachusetts, 02462, United States, 51-200 Employees
Phone Number: +16*********
Who is ALLENA PHARMACEUTICALS, INC.
Allena Pharmaceuticals is dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic disorders that affect the k...
Read More
-
Headquarters: 1 Newton Executive Park, Newton Lower Falls, Massachusetts, 02462, United States
-
Date Founded: 2011
-
Employees: 51-200
-
Revenue: 5 Million to 10 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 87
Does something look wrong? Fix it. | View contact records from ALLENA PHARMACEUTICALS, INC.
View Employees
Email
Phone
Similar Companies to Allena Pharmaceuticals, Inc.
Aapptec
-
51-200
-
$ 5 Million to 10 Million
Adela
-
51-200
-
$ 5 Million to 10 Million
Alloy Therapeutics
-
51-200
-
$ 5 Million to 10 Million
Allena Pharmaceuticals, Inc. Activity Score
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Allena Pharmaceuticals, Inc.
Answer: Allena Pharmaceuticals, Inc.'s headquarters are located at 1 Newton Executive Park, Newton Lower Falls, Massachusetts, 02462, United States
Answer: Allena Pharmaceuticals, Inc.'s phone number is +16*********
Answer: Allena Pharmaceuticals, Inc.'s official website is https://allenapharma.com
Answer: Allena Pharmaceuticals, Inc.'s revenue is 5 Million to 10 Million
Answer: Allena Pharmaceuticals, Inc.'s SIC: 87
Answer: Allena Pharmaceuticals, Inc. has 51-200 employees
Answer: Allena Pharmaceuticals, Inc. is in BIOTECHNOLOGY
Answer: Allena Pharmaceuticals, Inc. top competitors include: Microgem, Oncocyte, Evio Labs, Atai Life Sciences, Aapptec, Swift Biosciences, Unlearn, Adela, Alloy Therapeutics, Aspira Women's Health
Answer: Allena Pharmaceuticals, Inc. contact info: Phone number: +16********* Website: https://allenapharma.com
Answer: Allena Pharmaceuticals is dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic disorders that affect the kidney. The company is focused on metabolic disorders that result in excess accumulation of certain metabolites, such as oxalate and urate, that can cause kidney stones, damage the kidney, and potentially lead to chronic kidney disease, or CKD, and end-stage renal disease. Allena’s proprietary technological approach enables the design, formulation and delivery of non-absorbed and stable enzymes orally and in sufficient doses for activity in the GI tract. This approach utilizes the GI tract to degrade metabolites, such as oxalate and urate, reducing plasma and urine levels, and in turn, reducing their disease burden on the kidney over time. See our social media community guidelines - https://www.allenapharma.com/social-media-community-guidelines
Premium Sales Data for Prospecting
- Sales data across over 200M records
- Up-to-date records (less decayed data)
- Accurate Email Lists (real-world tested)
- Powerful search engine and intuitive interface
Get Full Access
View Employees
Allena Pharmaceuticals, Inc. Activity Score
Sign in to CIENCE GO Data to uncover contact details
Free credits every month